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Abstract
Background: Complex species-specific, developmental- and tissue-dependent mechanisms regulate alternative
splicing of tau, thereby diversifying tau protein synthesis. The functional role of alternative splicing of tau e.g. exon 10
has never been examined in vivo, although genetic studies suggest that it is important to neurodegenerative disease.
Results: Gene-targeting was used to delete exon 10 in murine tau on both alleles (E10−/−) to study its functional role.
Moreover, mice devoid of exon 10 (E10+/−) on one allele were generated to investigate the effects of 1:1 balanced
expression of 4R-/3R-tau protein, since equal amounts of 4R-/3R-tau protein are synthesized in human brain.
Middle-aged E10−/− mice displayed sensorimotor disturbances in the rotarod when compared to age-matched
E10+/− and wild-type mice, and their muscular grip strength was less than that of E10+/− mice. The performance of
E10+/− mice and wild-type mice (E10+/+) was similar in sensorimotor tests. Cognitive abilities or anxiety-like
behaviours did not depend on exon 10 in tau, and neither pathological inclusions nor gene-dependent morphological
abnormalities were found.
Conclusion: Ablation of exon 10 in the murine tau gene alters alternative splicing and tau protein synthesis
which results in mild sensorimotor phenotypes with aging. Presumably related microtubule-stabilizing genes
rescue other functions.
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Background
Tau belongs to the family of microtubule-associated pro-
teins (MAPs), which bind to and/or interact with micro-
tubule. It has been suggested that tau and other MAPs
serve to promote assembly of microtubule to make them
structurally stably, yet dynamic [1]. Disruption of the
tau gene led to structural abnormalities of microtubule
organization in small-calibre axons [2], and behavioural
deficits with hyperactivity, impaired motor strength and
coordination [3]. In contrast with the initial report [2],
there were in vitro phenotypes with delayed development
of neuronal polarity and formation of axons in cultured
embryonal hippocampal neurons from tau knockout mice
[4]. Functional redundancy, particularly between tau
and map genes likely exists, since map1a protein expres-
sion was enhanced in tau knockout mice [2,4]. Indeed
tau/map1b double knockout mice displayed brain anomal-
ies with severe defects on axon tract and neuronal layer
formation, together with abnormal growth cone morph-
ology and pronounced microtubule disorganization in pri-
mary neurons derived from these mice [5]. Tau protein
synthesis and function is regulated by alternative splicing
in a complex species-specific, developmental- and tissue-
dependent manner [6,7]. Depending upon the inclusion
or exclusion of exon 10, tau mRNA isoforms with three
(3R-tau mRNA) and four (4R-tau mRNA) microtubule
binding domains are generated, and in total six tau mRNA
isoforms are produced in the human brain. In the adult
human brain, splicing is balanced with a 1:1 expression
of 4R- and 3R-taumRNA [8,9]. This is in contrast to mouse
brain in which only 3R-tau mRNA is generated at birth and
only 4R-tau mRNA is synthesized at adulthood [7,10,11].
Thus equal amounts of 4R- and 3R-tau protein is synthe-
sized in adult human brain, while only 4R-tau protein is
produced in adult mouse brain. Interestingly, mutations
in exon 10 or in adjacent regulatory sequences, can give
rise to neurodegenerative disease with accumulation of
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filamentous inclusions of tau in the human brain. Regu-
lation of alternative splicing of tau is very complex and
partly unknown. In order to investigate the functional
role of exon 10 in murine tau we ablated the gene on
both alleles, and thereby generated E10−/− mice which
should in theory only synthesize 3R-tau protein. More-
over, the effect of a 1:1 balanced 3R-/4R-tau mRNA spli-
cing of human brain was examined by generating mice
in which exon 10 in tau was deleted on only one allele
(E10+/−). E10+/− mice should in theory synthesize equal
amounts of 3R- and 4R-tau protein, as in the human brain
(Additional file 1: Figure S1). The effects of fine-tuned regu-
lation of alternative splicing being critical to maintain neur-
onal functions and viability could thereby be assessed [12].
Here we show that E10−/− but not E10+/− mice, display
impaired sensorimotor abilities with aging.
Results
Generation of mice devoid of exon 10 in murine tau
Genomic regions (2.2 and 3.6 kbp) framing exon 10 in
the murine tau gene were amplified with high-fidelity
long-range PCR and subcloned into a pBluescript II
KS-vector that harboured a loxP-neomycin-loxP-cassette
(Figure 1A). The gene targeting construct was checked by
multiple restriction enzyme digests and sequencing of
both introns and the intervening neomycin cassette.
The gene-targeting vector was made linear with SspI
and introduced into R1 embryonic stem (ES) cell with
Figure 1 Gene targeting strategy and verification. (A) An outline of the murine tau gene (around exon 9–11) is shown, as well as the
targeting construct and the modified murine tau gene which was generated by homologous recombination. The null allele, lacking exon 10, was
generated by breeding mice harbouring the modified murine tau gene with pgk-CRE transgenic mice. (B) Identification of the recombined allele
in genomic DNA of embryonic stem cell (ES) clones 33 and 55 by PCR-analyses. Bands of expected sizes, 3.0 kbp (with primers a and b) and
4.0 kbp (with primers c and d) were detected in these clones, but not in ES clones 32 and 54. (C) PCR analysis with primers flanking the deleted
chromosomal region (primers e and f). Amplification of genomic DNA from E10+/− mouse (E10) resulted in two distinct bands, a 900 bp band
from the endogenous tau gene and a 460 bp band from the null allele. There was only a 900 bp band from the endogenous tau gene in
wild-type mouse (wt). Positive (+) and negative (neg) controls for the PCR reactions. Empty lanes (−).
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electroporation. ES cell clones were screened for hom-
ologous recombination and in a few clones, integration
in the murine tau locus led to deletion of exon 10 and ad-
jacent intron sequences (~200 bp on each side of exon 10).
The clones were screened with PCR-reactions in
which one primer was located outside the homologous
sequences of the targeting construct. Those experi-
ments resulted in 3.0 kbp and 4.0 kbp bands respect-
ively (Figure 1B). One of the positive ES cell clones
was microinjected into blastocysts and transplanted
into pseudopregnant mice. Male chimeric mice were
bred with C57Bl/6 J and their offspring were examined
for evidence of germ line transmission. These were
further bred with transgenic mice expressing phos-
phoglycerate kinase (pgk)-CRE recombinase to delete
the neo cassette. PCR with genomic DNA and primers
flanking exon 10 provided evidence of an endogenous
tau allele (900 bp) and a null allele (460 bp) in E10+/−mice,
while only a single band was present in wild-type siblings
(E10+/+; Figure 1C).
Lack of exon 10 in tau results in 3R-tau protein synthesis
in adult mouse brain
Next we investigated E10+/− mice for expected deviations
in tau mRNA expression and protein synthesis. RT-PCR
analyses were performed with primers located within
exon 9 and exon 11 to generate PCR products of 305 bp
(4R-tau mRNA) and 212 bp (3R-tau mRNA) respectively.
As expected, a 1-day-old wild-type mouse (wt; P1)
expressed only 3R-tau mRNA, while a 9-days-old wild-type
mouse (P9) generated equal amounts of 3R- and 4R-tau
mRNA due to alternative splicing (Figure 2A). An 18-
days-old wild-type mouse (P18) produced only 4R-tau
mRNA. In contrast, a 2-months-old E10+/− mouse (E10)
generated 3R- and 4R-tau mRNA in essentially equal
proportions, while only 4R-tau mRNA was produced
in an age-matched wild-type mouse (Figure 2A). Pro-
tein synthesis was examined with RD3 antibody, which
is selective for 3R-tau, by western blot and immunohis-
tochemistry. On western blot, all three isoforms of 3R-
tau were found in E10+/− (E10) mouse brain, but the
isoform devoid of exon 2 and 3 was the predominant
(Figure 2B and Additional file 1: Figure S1). Tau-1, an
antibody which recognizes both 3R- and 4R-tau, generated
extra protein bands in E10+/− (E10) mice as compared to
wild-type (wt) mice (Figure 2C). The results were consist-
ent with 3R-tau protein synthesis in E10+/− (E10) mouse
brain. Immunohistochemistry with RD3 antibody resulted
in strong staining in the stratum radiatum in CA1-CA3
areas of the hippocampus and faint staining in the soma
of pyramidal neurons in adult E10+/− mice (Figure 2D),
but not in wild-type mice who did not express 3R-tau
protein (Figure 2E). In contrast, the non-selective Tau-1
antibody showed a staining pattern consistent with tau
being mainly confined to the axonal compartment [13]
in both adult E10+/− (Figure 2F) and in wild-type mice
(Figure 2G). There was no immunostaining in the absence
of a primary antibody (Figure 2H-I).
Absence of exon10 in tau results in age-dependent
sensorimotor dysfunctions
Subsequently, we aimed to investigate the physiological
and functional role of exon 10 in tau. In previous reports,
tau knockout mice developed sensorimotor dysfunctions
due to loss of tau protein synthesis [3]. Cerebellum, which
is implicated in balance and motor learning, develops at
postnatal stages when 4R-tau is normally produced. We
therefore examined whether partial or complete absence
of exon 10 in tau led to sensorimotor anomalies in
adult (5–6 months) and middle-aged (13–17 months)
gene-manipulated mice. Rotarod and grip strength
meter were used to assess sensorimotor dysfunctions.
Genotype-dependent motor coordination dysfunction was
not detected among adult mice (Figure 3A, F(2,50) = 0.27;
p = 0.76), while differences in rotarod performance were
observed among middle-aged mice (F(2,46) = 4.34; p < 0.05).
Post-hoc analyses showed that E10−/− mice were impaired
compared to E10+/+ (p < 0.05) and E10+/− (p < 0.01,
Figure 3B). Similar results were found when the highest
speed at which the animals remained on the rotarod was
used as outcome measure (Additional file 1: Figure S2,
F(2.46) = 5.05; p < 0.05). Post-hoc analyses revealed
that the muscular strength of adult E10+/− mice was
superior to that of E10+/+ mice (Figure 3C; p < 0.05).
In contrast, middle-aged E10−/− mice were weaker
than E10+/− (p < 0.05), but not E10+/+ mice (p = 0.10;
F(2,45) = 2.43; Figure 3D).
E10−/− mice are less active than E10+/− mice in IntelliCage
The effect of partial and complete deletion of tau exon
10 on general behaviour and cognitive function was
assessed in IntelliCages, a new non-invasive system for
behavioural phenotyping [14,15]. Since the behaviours
of E10+/− and wild-type mice (E10+/+) in sensori-
motor tests were essentially equal, we chose to only
examine two experimental groups, 9–10 months-old
E10+/− and E10−/− mice. Moreover we wanted to in-
crease group size and statistical power. First, tendency
to explore and habituate to novel environment was exam-
ined. During the first 2 hours of the study, the LEDs were
turned on in two of the four corners. The E10−/− mice
(61.2 ± 4.2%, n = 10) spent more time in the illuminated
corners than E10+/− mice (46.6 ± 4.8%, n = 9; t(17) = −2.31,
p < 0.05). During the first 24 hours, E10+/− mice (64 ± 17,
n = 10) tended to perform more visits to the corners
than E10−/− mice (28 ± 10, n = 12; Mann Whitney
U = 31, p = 0.06). As previously observed, there was a
marked diurnal activity pattern, i.e. more activity
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during the dark phases compared to light phases.
There was a significant time-dependent decrease in
the number of corner visits (F(13,260) = 7.0, p < 0.001)
indicating that E10+/− and E10−/− habituated to the
new environment (Figure 4A). Interestingly, during
the habituation, E10+/− mice were significantly more
active than E10−/− mice (F(1,20) = 8.87, p < 0.01;
Figure 4A). The amount of time spent drinking, mea-
sured as lick duration, increased over days for both
groups of mice (F(13,260) = 6.74, p < 0.001, data not
Figure 2 Tau mRNA and protein expression in E10+/− and wild-type mice. (A) Only 3R-tau mRNA (212 bp) was expressed at birth (P1) in
wild-type mice (wt). At (P9), 3R-tau and 4R-tau mRNA (305 bp) was expressed, while at (P18) and in 2-month-old wt-mice, exon 10 was included
and 4R tau mRNA was expressed. In contrast, 2-month-old E10+/− mice (E10) produced 3R-tau and 4R-tau mRNA in equal proportions. Signals
depended on mRNA and reverse transcriptase in the cDNA synthesis reaction (−RT, E10). (B) Left; Western blot with a selective antibody for 3R
tau resulted in a 38 kDa band in 2 months-old E10+/− mouse brain (E10). Right; Two additional bands were seen when films were overexposed.
These bands likely represented tau-isoforms with N-terminal domains exon 2 and 3. In an age-matched wt-mouse there was only a small amount
of 3R-tau protein. (C) Left; An antibody (Tau-1) that recognizes 3R-tau as well as 4R-tau generated two protein bands at 38 and 39 kDa in brains
of 2-month-old E10+/− mice (E10). Right; Overexposure results in two additional double bands likely representing isoforms of tau with the N-terminal
domains exon 2 and 3 of tau protein. Only a small amount of 3R tau protein was found in age-matched wild-type littermates (wt). Recombinant
human tau protein representing all tau isoforms and a newborn wild-type mouse brain (P1) was included as a positive control. (D) Immunostaining
with selective antibody 3RD showed that 3R-tau was mainly localized in axons of E10+/− mice, (E) but not present in an age-matched wild-type mice.
(F-G) The non-selective antibody Tau-1, which recognizes both 3R-tau and 4R-tau, stained hippocampal layers which are rich in axons in both
E10+/− (F) and wild-type mice (G). (H-I) No immunostaining in E10+/− (H) or wild-type mice in the absence of primary antibody (I).
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shown), but the length of lick duration did not differ
between genotypes. Despite a habituation effect, three
E10−/− mice performed few corner visits and drank
little, and therefore had to be excluded. They were re-
placed by four new E10−/− mice, which were allowed
to habituate to the IntelliCages for additional 7 days.
The inserted mice were initially very active, with high
numbers of corner visits. In the following days, the
number of corner visits drastically decreased. Their ac-
tivity was not significantly different from the rest of
the mice during the last three days of the habituation.
Place learning or associative learning do not depend on
the presence of exon 10 in tau
The IntelliCages are equipped with four corners, each
with two doors leading to their respective water bottle.
In the Place learning protocol, an error was defined as
a nosepoke on any of the seven doors where sucrose
water (reward) was not available, i.e. the closed side of
each corner (=four doors) and the accessible side in
the three corners where only water was available
(=three doors). Any visit to a door where reward was
not provided was defined as an erroneous behaviour.
The percentage of errors made by E10−/− mice decreased
from the first day of testing to the last day (from 84.2 ±
4.6% to 63.6 ± 8.9%, p = 0.06; chance level is 87.5%). Like-
wise, the percentage of errors decreased for E10+/− mice
from 95.3 ± 2.3% to 79.8 ± 6.0% (p < 0.05). However, spatial
learning ability did not depend on genotype (Figure 4B).
During reversal learning, when reward was provided
behind the diagonally opposite door, E10−/− mice made
more errors on first 84.2 ± 5.5% than on the last day of
testing 59.7 ± 8.7% (p < 0.05; chance level is 87.5%), but
this was not observed for E10+/− mice (82.8 ± 5.7% to
79.7 ± 6.2%, p = 0.72; Figure 4C). Again, reversal learn-
ing did not depend on genotype. When mice again
could access water behind all eight doors (extinction of
Place learning, 12 hours), E10+/− and E10−/− mice
preferred the previously rewarded location (t(38) = 2.09,
p < 0.05 i.e. above chance level 12.5%; Figure 4D), i.e. they
still preferred the location where reward had been
provided during the reversal learning. To assess cogni-
tive function, E10+/− and E10−/− mice were also
exposed to a passive avoidance test with a memory
probe trial [16]. At baseline, before being exposed to an
aversive stimulus, neither of the gene-manipulated
mice preferred any of the four corners (Figure 4E; left).
During training, the mice avoided the corner in which
Figure 3 Sensorimotor functions of wild-type, E10+/− and E10−/− mice. (A) Mice devoid of tau exon 10 (E10−/−) showed no deficits in
rotarod when they were 5–6 months-old (E10+/+, n = 19; E10+/−, n = 17; E10−/−; n = 17), (B) but when compared to wild-type (E10+/+, p < 0.05)
and E10+/− (p < 0.01) their performance was impaired when they were 13–17 months-old (E10+/+, n = 18; E10+/−, n = 16; E10−/−; n = 15).
(C) 5–6 months-old wild-type mice (E10+/+) were weaker than E10+/− (p < 0.05: E10+/+, n = 9; E10+/−, n = 8; E10−/−; n = 8), (D) while
13–17 months-old E10−/− mice were weaker than E10+/− (p < 0.05). *p < 0.05; **p < 0.01.
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they were exposed to an aversive stimuli (an air-puff ),
but there was no genotype-dependent difference (training
t(18) = 1.07, p = 0.30; probe trial t(18) = 0.35, p = 0.73;
chance level is 25%; Figure 4E; middle). In the probe trial,
both E10+/− and E10−/− mice avoided the corner where
they had previously been exposed to an aversive stimuli
(training t(38) = 11.9, p < 0.001; probe trial t(38) = 9.84,
p < 0.001; chance level is 25%; Figure 4E; right). These
findings were indicative of learning and memory reten-
tion abilities in both groups of gene-manipulated mice.
No genotype-dependent effects on anxiety-like or
exploratory behaviours
Since, E10−/− mice were less active than E10+/− mice in
the intelliCages we wanted to further examine locomotion,
emotionality and explorative behaviours with traditional be-
havioural tests. Behaviour in elevated plus maze is thought
to reflect anxiety and risk aversion, while open field mea-
sures activity and willingness to explore novel environment.
There were no genotype-dependent differences in the open
field test. The different mice did not differ in terms of
Figure 4 Activity and learning ability of E10+/− and E10−/− mice in IntelliCage. (A) 9–10 months-old mice devoid of tau exon 10 (E10−/−)
were less active when habituating to IntelliCages as compared to E10+/− mice (E10+/−, n = 10; E10−/−; n = 12). No genotype-dependent
differences were observed during (B) Place learning, (C) Reversal learning and (D) Extinction of place learning (E10+/−, n = 10; E10−/−; n = 10).
(D) The results were indicative of response perseverance since the previously rewarded corner (rewarded RL learning; p < 0.001) was preferred
when compared to chance level (dotted line, 12.5%) when all locations were again made accessible for drinking. (E) In passive avoidance, the
mice significantly avoided those corners in which an aversive stimulus had been given during training (p < 0.001) and probe trial (p < 0.001)
when compared to chance level (dotted line, 25%), i.e. the animals learnt and remembered but there were no genotype-dependent differences
in associative learning or memory. *p < 0.05; **p < 0.01; ***p < 0.001.
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location preference (center F(2) = 0.03, p = 0.97); internal
F(2) = 0.04, p = 0.96); periphery F(2) = 0.60, p = 0.56;
Figure 5A), distance moved (Additional file 1: Figure S3)
or rearing activity (F(2) = 0.49, p = 0.62; Figure 5B). Similarly
in the elevated plus maze, gene-manipulated mice were
equally unwilling to spend time in the open arms as
wild-type (E10+/+) mice (center F(2) = 1.39, p = 0.27);
closed arms F(2) = 0.038, p = 0.96); open arms F(2) = 0.36,
p = 0.70; Figure 5C).
Deletion of exon 10 does not result in gross
morphological abnormalities or tauopathy
Brains of 12 months-old wild-type (E10+/+), E10+/− and
E10−/− mice were examined for major structural changes.
Sections were stained with hematoxylin and luxol fast
blue dyes, but we did not find any genotype-dependent
differences in the forebrain, cerebellum or spinal cord
(Figure 6). The astroglial marker, glial fibrillary acidic-
protein (GFAP) was used as a rather unspecific sensor
of abnormalities in brain tissue. However, we did not
find any differences between the mice (Figure 7). Simi-
larly, there were no genotype-dependent differences in
GFAP-staining in cerebellar tissue (data not shown) and no
macroscopic differences of whole brain (Additional file 1:
Figure S4). We were unable to find any evidence of tau ag-
gregation in the brains of E10+/− or E10−/− mice (data not
shown).
Discussion
The cytoskeleton helps cells maintain a dynamic cellular
morphology in response to the demands of the sur-
rounding environment. Microtubule-binding proteins
likely play a major role in cytoskeletal integrity which
is highly critical to neuronal functions and viability,
since it enables bidirectional axonal transport of vesi-
cles and organelles along extended processes. In the
adult human brain, splicing of tau protein gives rise to
a 1:1 balanced expression of 3R- and 4R-tau mRNA,
while in rodents only 4R-tau mRNA is expressed in
adult animals. Interestingly, in mouse brain exon 10 is
not utilized for protein synthesis until postnatal stages
[11,17], when the genome might be less able to activate
compensatory mechanisms and mask phenotypes. This
is the first study in which the splicing pattern of tau, a
microtubule-binding protein, has been altered in the
genome with the purpose of studying physiological
functions of exon 10 in vivo. Gene targeting is typically
associated with the creation of knockout mice, often
generated by ablating the basal promoter and exon 1.
There are a few reports in which the technique has
been used to solely eliminate a single exon [18]. In the
current study, equal amounts of 3R- and 4R-tau protein
were synthesized in 2 months-old E10+/− mice while
wild-type littermates only expressed 4R-tau protein.
Moreover, immunostaining with a 3R-tau selective anti-
body confirmed axonal localization of tau in genetically
Figure 5 Exploratory behaviour of wild-type, E10+/− and E10−/− mice. (A) 12–16 months-old wild-type (E10+/+; n = 9), E10+/− (n = 7) and
E10−/− (n = 6) mice explored the different compartments of the open field apparatus to the same extent. (B) Rearing activity was similar between
the genotypes. (C) Behaviour in the elevated plus maze did not depend upon partial or complete ablation of exon 10.
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manipulated mice (E10+/−). Altogether, gene targeting
technique led us to the successful generation of gene-
manipulated mice expressing 3R:4R-tau (E10+/−) and
3R-tau (E10−/−) mRNA and protein with expected
subcellular localization.
Functional studies revealed an age-dependent decline
of sensorimotor skills only in middle-aged E10−/− mice.
Adult and middle-aged E10+/− mice had similar motor
skills in the rotarod test as E10+/+ mice, consistent with
haploinsufficiency seldom giving phenotypes in knockout
studies. Interestingly, adult (5–6 months) E10+/− mice
were actually stronger than E10+/+ mice, which could
be explained by activation of compensatory mechanisms.
It has been suggested that other microtubule-associated
proteins, MAP1A and MAP1B, are involved in functional
compensation. Ablation of tau resulted in ~2-fold increased
MAP1A levels in young mice (~2 weeks old) [2,4], while
levels of MAP1B and other MAPs remained unchanged.
Compensatory mechanisms seem more active during
embryogenesis and early postnatal development, since
MAP1A was unchanged in 12 months-old tau knockout
mice [4]. We speculate that functional compensation
in adult E10−/− mice was overridden by the effects of
aging, resulting in sensorimotor deficits.
Cognitive and emotional functions in the gene-
manipulated mice were examined, partly because tau
anomalies are related to dementia disorders. We decided
to restrict IntelliCage analyses to two groups of mice;
E10+/− and E10−/− because we wanted to attain a rea-
sonable statistical power. The decision was also due to
Figure 6 Gross morphology of wild-type, E10+/− and E10−/− mice. Coronal sections from 12 months-old mice which were stained with
hematoxylin and Luxol fast blue dyes. There were no apparent genotype-dependent differences in (A-F) forebrain, (G-I) hind brain or (J-O)
spinal cord. Scale bar measures 500 μm (A-C, G-I), 250 μm (J-L), 125 μm (D-F) and 63 μm (M-O).
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availability of IntelliCages and female mice well matched
for age. Moreover E10+/− and E10+/+ mice had behaved
essentially the same in the sensorimotor tests. These
observations were consistent with many other knockout
studies, in which haploinsufficiency seldom results in phe-
notypes. E10−/− mice were less active than E10+/− mice
in the IntelliCages, observations which were not reflected
in differential anxiety-like behaviours or diminished
exploratory behaviour when animals were tested in
open field or elevated plus maze. In IntelliCages, mice
are housed for days undisturbed in social groups in an
environment to which they are allowed to habituate.
The procedures of open field and elevated maze testing
are markedly different, and this can of course have an
impact on the outcome. Both groups habituated well to
the new environment and did not show overt cognitive
dysfunctions in IntelliCages. We conclude that dele-
tion of exon 10 in tau does not result in cognitive or
emotional phenotypes, although it remains to be inves-
tigated if this occurs with aging.
Taken together phenotypes in mice genetically manipu-
lated around exon 10 in tau were limited to sensorimotor
defects and partly similar to those found in tau knockout
mice [3,19]. Impaired performance might relate to cerebel-
lar dysfunctions, since this brain region to a large extent
develops at postnatal stages when splicing of tau-mRNA
is abnormal in E10+/− and E10−/− mice [20]. We were
unable to find gross morphological changes, but there
could be subtle differences in neural tree or synapto-
dendritic connections leading to network dysfunctions.
Electrophysiological and high-resolution quantitative
morphology would be needed to investigate such changes,
studies which we consider to be outside the scope of an
initial characterization of the models.
There is evidence to suggest that in tauopathies, the
pathological aggregation of tau can be primary patho-
genic e.g. in frontotemporal lobe dementia (FTLD-17)
or secondary pathogenic e.g. to Aβ-aggregation in AD
[21]. However, it remains unclear why human Aβ accu-
mulation by itself does not generate neurofibrillary
tangles in AβPP transgenic mice. Perhaps structural
differences make murine tau unable to form fibrils but
in vitro experiments contradict this theory [22]. Murine
tau can take part in tau aggregation in vivo but so far
seems unable to initiate tau pathology by itself [23-25].
An unknown factor or a trigger, such as misfolded or
aggregated human tau or perhaps Aβ seems to be crit-
ical. The differences in splicing of tau in mouse and
human brain, i.e. the 1:1 balanced 3R-/4R-tau mRNA
splicing pattern, could directly impact on the stability
of the microtubule structure and on aggregation of tau.
It remains to be investigated whether the microtubule
system of E10+/− and E10−/− mice is more vulnerable
to a trigger of tau-misfolding e.g. an aggregate of hu-
man Aβ or human tau than wild-type mice harbouring
intact murine tau (E10+/+).
Conclusions
This is the first functional study of exon 10 in tau, which
is linked to neurodegenerative disease. By deleting exon
10 it was possible to alter alternative splicing of tau
such that 3R-tau protein was synthesized instead of
4R-tau protein. The anatomic and subcellular localization
of tau protein synthesis was maintained in the gene-
manipulated animals. Middle-aged mice lacking exon
10 in tau (E10−/−), expressed only 3R-tau protein and
displayed mild sensorimotor deficits with reduced grip
strength and motor coordination. Haploinsufficient mice
Figure 7 Astroglial immunostaining in the hippocampus of wild-type, E10+/− and E10−/− mice. Coronal sections from 12 months-old
mice were stained with a GFAP-antibody. Differences in glial staining were not apparent in E10+/− and E10−/− mice when compared to wild-
type (E10+/+) mice. Magnification of CA1 region is marked with arrowheads. Scale bars measure (A-C) 500 μm or (D-F) 125 μm.
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(E10+/−), expressing both 3R- and 4R-tau protein, behaved
nearly always equal to wild-type mice (E10+/+) which
expressed only 4R-tau protein. There were no genotype-
dependent effects on cognition, emotionality or on gross
brain structure and tissue morphology. Thus, sensori-
motor functions depend on tau exon 10, while perhaps
additional functions are masked by related microtubule-
binding proteins.
Methods
Ethical note
Appropriate experimental procedures were approved by
the committee of ethical conduct in research on animal
at the Uppsala University (ethical permits C17/7 (2007-
03-02 – 2010-03-02), C374/9 (2010-01-29 – 2013-01-29)
and C278/12 (2012-12-20 – present) and performed
according to guidelines of ethical conduct on science
in compliance with local animal care.
Gene targeting
A 2.2-kbp genomic fragment in intron 9 of the murine tau
gene was amplified with genomic DNA from R1 embryonic
stem (ES) cells as template using high-fidelity Expand
PCR system (Roche, Basel, Switzerland). Primers started
at 15718139 and 15720351 respectively in NT_165773.2.
Likewise a 3.6-kbp fragment stretching from intron 10 into
intron 11 was amplified with primers starting at 15720889
and 15724540 in NT_165773.2. Primers were designed as
to avoid ~200 bp intron sequences located in introns 9
and 10, immediately adjacent to exon 10. Both genomic
fragments were inserted into the pBluescript II KS-
vector where they flanked a 2 kbp fragment containing a
neomycin gene surrounded by loxP-sites that had been
excised from the pKK7-vector. The targeting construct
was checked by multiple restriction enzyme digests and
fully sequenced. Only a few mismatches were found as
compared to the NCBI database. None of those were
located in or adjacent to protein coding sequences. The
targeting construct was introduced into R1 ES cells by
electroporation and homologous recombination was
verified in 7 out of 375 individual clones by screening
with two long-range PCR reactions. In both reactions,
one primer annealed to sequences outside the targeted
allele (starting at 15717864 and 15724785 respectively)
while the other primer annealed to sequences within the
neomycin (neo) gene. Male chimeras were obtained by
microinjection of ES cell clones into blastocysts and
subsequent transplantation of these blastocysts to CD1
pseudopregnant mice. The blastocysts were generated
by mating with C57BL/6NCrl females and B6D2F1/Crl
males, Male chimeras were bred with female C57Bl/
6JBomTac mice (Taconic, Hudson, NY, USA) as to gen-
erate female offspring, which were then bred with male
transgenic mice expressing phosphoglycerate kinase
(pgk)-CRE recombinase (BALB/c × C57B1/B6)F1 [26].
The loxP-flanked neo-cassette was thereby deleted from
the targeted allele in some of the offspring.
PCR analyses of genomic DNA and mRNA
Genomic DNA from ear-biopsies was prepared as pre-
viously described [27]. PCR amplification was done
with primers annealing at 15720175 and 15721073 in
NT_165773.2 as to frame exon 10 in the murine tau
gene and to generate ~900 or ~460 bp bands depending
upon the inclusion or exclusion of exon 10. Alternatively
the targeted allele was identified by using with one primer
located in the ~100 bp sequence adjacent to the remaining
loxP-site, and therefore unique to the targeted allele, and
the other primer in nearby intron sequences of the murine
tau gene. Total RNA was purified with RNA STAT-60
(Tel-Test, Friendwood, TX, USA), which is based on the
guanidine thiocyanate method. Universal Riboclone cDNA
synthesis system (Promega, Madison, WI, USA) and an
antisense primer located at 1281–1262 in NM_010838.3
were used for first strand synthesis. The nascent cDNA
was then PCR amplified with primers which annealed
at 671–690 (in exon 9) and 975–954 (in exon 11) in
NM_010838.3 as to simultaneously assay 3R-tau and
4R-tau mRNA expression. Alternatively cDNA was ampli-
fied with primers located at 671–690 (in exon 9) and 893–
876 (in exon 10) whereby only 4R-tau mRNA was detected.
The PCR products were separated by electrophoresis on
ethidium bromide-stained agarose gels, and examined and
photographed under UV-light.
Histology and western blot
Mice were anesthetized with 0.4 ml Avertin (25 mg/ml)
and intracardially perfused with 0.9% (w/v) saline solu-
tion. Brains were dissected and either directly frozen on
dry ice for western blot analyses, or instantly frozen in
2-methylbutane at −30°C with dry ice and used for im-
munohistochemistry. All tissues were stored at −80°C
until use. Sections, 14 μm, were cut in a cryostat, fixed
in 4% formalin for 5 min, permeabilized in 0.4% Triton
X-100 for 5 min and treated with 0.3% H2O2 for 15 min
to eliminate endogenous peroxidase activity. Tissues
were then incubated with DAKO-block for 1 h to block
unspecific signal and then with primary antibodies 3RD
(x40) and Tau-1 (×200) (Millipore, Billerica, MA, USA)
over night at +4°C. Sections were then washed and treated
with secondary antibodies, ABC-reagents and developed
with NOVA RED as described [28]. For Cresyl violet and
Luxol fast-blue staining, mice were intracardially perfused
with 4% (w/v) formaldehyde solution and neuronal tissues
were dissected and immersed in this solution for 3 days,
dehydrated in etOH (40% 2×4 h; 70% o.n.; 80% 2×1.5 h;
95% 2×1.5 h; 100% 2×1 h; Xylen 2×30 min), immersed in
paraffin o.n at 62°C, embedded and sectioned at 5 μm.
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Brains used for western blot were extracted in 10 mM
Tris, 0.8 M NaCl, 1 mM EDTA, 10% (w/v) sucrose supple-
mented with Complete® (1:50) protease inhibitor cocktail
(Roche, Basel, Switzerland) and centrifuged at 26 000 × g
for 20 min at +4°C. The pellet was extracted and centri-
fuged again at 26 000 × g for 20 min at +4°C. The super-
natants were pooled and supplemented with 1% (w/v)
sarkosyl and incubated by rotary shaking at 200 RPM
for 1 h at RT. The mixture was then centrifuged at 100
000 × g for 1 h at +4°C and the sarkosyl-soluble supernatants
were run on 8% Tris-Glycine gels (InVitrogen, Carlsbad,
CA, USA) and analyzed with western blot as previously
described [28]. A human recombinant tau protein ladder
was used as size markers (rPeptide, Bogart, GA, USA).
Nitrocellulose filters were incubated with primary anti-
bodies 3RD (x20 000) and Tau-1 (x50 000) in 5% (w/v)
non-fat dry milk in 1×TTBS for 1 h at RT.
Rotarod
Motor coordination of wild-type (E10+/+), E10+/− and
E10−/−mice was assessed at 5–7 months and 13–17 months
of age. The ROTA-ROD apparatus (dimensions 362 ×
240 × 400 mm) (model LE8200, Panlab, S.L.U., Spain)
consisted of a vertical plastic (methacrylate) rotating rod
(dimensions 50 × 30 mm) with a ribbed surface flanked by
two large discs (arnite). Each mouse was given three trials
with 10 min inter-trial interval for three consecutive days.
Trials started at a minimum speed of 4 rpm followed by
5 min acceleration time (maximum speed 40 rpm) with
increase of speed with 1 rpm every 8th second. The latency
to fall and the rotation speed when the mice fell was
recorded. The apparatus was cleaned with 70% ethanol
between trials.
Grip strength
Muscular strength of wild-type (E10+/+), E10+/− and
E10−/− mice was evaluated at 5–7 months and 13–
17 months of age. The grip strength meter (model
GS3, BIOSEB, Chaville, France) consisted of a stainless
steel grid (dimensions 100 × 80 mm) with a sensor capacity
ranging 0–20 Newton (N). Each mouse was held by the tail,
placed on the grid with all four paws and gently pulled
horizontally by the tail along a straight line until the mice
released the grid and the maximum forced was recorded.
Each mouse was given three trials with 30 seconds inter-
trial interval for four consecutive days. The stainless grid
was cleaned with 70% ethanol between trials.
IntelliCage
Behaviours of female E10+/− and E10−/− mice housed
in social groups were tested at 9–11 months of age. The
protocols used have been previously described in detail
[14]. Each IntelliCage was equipped with four learning
corners accessible through a ring antenna which led to
two mechanical doors controlling access to two water
bottles. Light-emitting diodes (LEDs; colour code 1638)
were located above each door inside the learning corners.
Three events were recorded in the learning corners; visit,
nosepoke and lick. A visit was recorded when the ring an-
tenna detected the microchip and the heat sensor simul-
taneously sensed a temperature shift. A nosepoke was
recorded when the infrared beam in front of the mechan-
ical door was interrupted. A lick was recorded when a
mouse touched the nipple of the water bottle such that
the “lick sensor” exceeded a threshold level. IntelliCage
software (ver. 2.4.2) and IntelliCage corners (ver. 2.0) were
used (http://www.newbehavior.com). The animals were
allowed to habituate to the testing room for a week, and
were then under isoflurane anaesthesia subcutaneously
injected with transponders in the interscapular area. At
least 24 h after transponder implantation, the mice were
placed into the IntelliCages at the beginning of the dark
phase. The duration of IntelliCage housing was 6 weeks,
during which the dark phase was scheduled from 20:00
until 08:00 and light phase 08:00–20:00. The modules,
which are listed in Table 1, have previously been exten-
sively reported [14], and here only deviations from those
protocols are described:
Elevated plus maze
Anxiety-like behaviours of 12–16 months-old wild-type
(E10+/+), E10+/− and E10−/− mice were assessed in a
maze made of grey coloured PVC walls (model LE842,
Panlab S.L.U., Barcelona, Spain). It consisted of two open
arms and two closed arms (length 29.5 cm and width 6 cm)
arranged as a cross. The center was 6 × 6 cm and the closed
arms were protected by a 15 cm wall made of grey PVC.
Individual mice were placed at the center of the maze
Table 1 Behavioural analyses in the IntelliCage
Name of the module Duration (days)
1. Free exploration (FE) 1
2. Habituation 14
3. Place learning (PL) 4
4. Reversal place learning (RevPL) 4
5. Extinction of place preference 2
6. Passive avoidance 3
A) Place learning (PL): In a designated corner for each mouse, a nosepoke
opened the left door once during a visit. Thereby the animals were given
access to 300 mM sucrose (rewarded corner) during two drinking sessions per
night (23:00–24:00 and 04:00–05:00). The right door in the same corner
remained closed. In the other three corners, a nosepoke opened the right
door which gave access to water (unrewarded corner) once during the two
drinking sessions. The left door remained closed during the rest of time. The
corner in which reward was given was randomized and individual designated
to each mouse.
(B) Reversal learning during drinking sessions (revPL): The same protocol as PL
except that the respective corner giving access to sucrose was the
diagonal opposite.
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facing the open arms for a single 5 min trial. Their be-
haviours were recorded on video and analysed with
Smart Junior program V1.0. The maze was cleaned with
70% ethanol between trials.
Open-field test
A transparent cage (width 37 cm, length 48 cm and height
20 cm) was used to assess locomotor activity, exploratory
and anxiety-like behaviours of 12–16 months-old wild-type
(E10+/+), E10+/− and E10−/− mice. Individual mice
were placed at the center of the cage for 10 min and
their behaviour was recorded with a video camera. The
testing cage was divided in three zones: periphery, internal
and center comprising 43.6%, 48.6% and 7.8% of the total
area respectively. Off-line analysis of the records was
performed with Smart Junior program V1.0. The area
was cleaned with 70% ethanol between trials.
Statistical analyses
GraphPad (San Diego, CA, USA) and Statistica (Tulsa,
OK, USA) were used. Data which had been verified not
to deviate from a normal distribution were analyzed with
unpaired t-test, one-way or two-way ANOVA, or otherwise
with a non-parametric test e.g. Mann–Whitney U-test.
Outliners were identified with Grubbs’ test, and post-hoc
test of one-way and two-way ANOVA were analyzed with
Fisher LSD. Results presented are mean ± s.e.m. unless
otherwise stated.
Additional file
Additional file 1: Figure S1. A graphical illustration of the genomic
structure around exon 10 on both alleles in the murine tau gene locus,
tau mRNA expression and tau protein synthesis in wild-type (E10+/+, upper),
E10+/- (middle) and E10-/- mice (lower). A part of the tau locus with exons 9,
11 (yellow), 10 (orange, dotted lines) and genetic deletion (►) is shown. The
four microtubule domains (R1-R4) in tau protein are encoded by exons 9-12
in tau. Alternative splicing of tau in adult wild-type mouse brain results in
4R-tau protein being synthesized by both alleles (upper). Ablation of exon 10
on one of the two alleles in tau (E10+/- mice) should theoretically lead to a
1:1 balanced ratio of 3R- and 4R-tau protein synthesis (middle). This mixture
of 3R-/4R-tau protein synthesis is found in adult human brain. In contrast,
lack of exon 10 on both alleles in tau (E10-/-) should results in 3R-tau protein
synthesis by both alleles (lower). Figure S2. Sensorimotor functions of
wild-type (E10+/+), E10+/- and E10-/- mice. 13-17 months-old mice devoid
of tau exon 10 (E10-/-) were also impaired in rotarod when maximum speed
was recorded compared to E10+/+ (p < 0.05) and E10+/- mice (p < 0.01)
(E10+/+, n = 18; E10+/-, n = 16; E10-/-; n = 15). *p < 0.05 and **p < 0.01.
Figure S3. Exploratory behaviours of wild-type E10(+/+), E10+/- and
E10-/- mice. At 12-16 months of age, E10+/- and E10-/- mice travelled a
similar distance in the open field apparatus as wild-type mice. Figure
S4. No macroscopic differences between brains of wild-type (E10+/+)
and E10+/- and E10-/- mice.
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